Skip to main content
NeuronFeed
Home Investors OrbiMed

OrbiMed

Active VC
Portfolio Active
2
Latest Treeline Biosciences
Deal flow
$310M
2 rounds
Unicorns
0
≥ $1B valuation
Founded
—
Latest
Aug 2025
Treeline Biosciences

About OrbiMed

Venture capital firm tracking 2 AI investments, with focus on Drug Discovery and US startups. Total tracked deal flow: $310M.

Sector focus

💊 Drug Discovery 2
🩺 AI Medical 1

Geographic focus

US 2

Portfolio

2

Treeline Biosciences

Computational and experimental drug discovery for hard-to-drug cancer targets

RayThera

AI-driven small-molecule discovery for safer, more effective immunology drugs

Co-investors

8

TTM Capital

1 shared

Foresite Capital

1 shared

Exor

1 shared

Rock Springs Capital

1 shared

Aisling Capital

1 shared

Fidelity Investments

1 shared

Casdin Capital

1 shared

Ajax Health

1 shared

Recent rounds

2
Aug 21, 2025 Series A $200M Treeline Biosciences
Series A $110M RayThera